MiR-210-5p promotes the differentiation of human induced pluripotent stem cells into dopaminergic neural precursors by targeting SMAD4 and SUFU and treats parkinsonian rats.

MLA

Lyu, Ying, et al. “MiR-210-5p Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Dopaminergic Neural Precursors by Targeting SMAD4 and SUFU and Treats Parkinsonian Rats.” Experimental Gerontology, vol. 179, Aug. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.exger.2023.112243.

APA

Lyu, Y., Su, Z., Ye, G., He, X., Liu, Y., Yin, Q., Xie, F., Xu, L., Chen, Y., & Long, D. (2023). MiR-210-5p promotes the differentiation of human induced pluripotent stem cells into dopaminergic neural precursors by targeting SMAD4 and SUFU and treats parkinsonian rats. Experimental Gerontology, 179, N.PAG. https://doi.org/10.1016/j.exger.2023.112243

Chicago

Lyu, Ying, Zhongqiang Su, Guosheng Ye, Xiulan He, Yue Liu, Qiao Yin, Fanbing Xie, Liping Xu, Yuncai Chen, and Dahong Long. 2023. “MiR-210-5p Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Dopaminergic Neural Precursors by Targeting SMAD4 and SUFU and Treats Parkinsonian Rats.” Experimental Gerontology 179 (August): N.PAG. doi:10.1016/j.exger.2023.112243.